Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Peroxisome Proliferator-Activated Receptors, Pulmonary Hypertension Research and Treatments, Eicosanoids and Hypertension Pharmacology, and COVID-19 Clinical Research Studies.
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
Lung-Targeted Delivery of Dimethyl Fumarate Promotes the Reversal of Age-Dependent Established Lung Fibrosis
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
PPARγ Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation
Time-dependent PPARγ Modulation of HIF-1α Signaling in Hypoxic Pulmonary Artery Smooth Muscle Cells
Peroxisome Proliferator–Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling
Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation
Hypoxia downregulates PPARγ via an ERK1/2–NF-κB–Nox4-dependent mechanism in human pulmonary artery smooth muscle cells
The Nox4 Inhibitor GKT137831 Attenuates Hypoxia-Induced Pulmonary Vascular Cell Proliferation
Endothelial Cell Peroxisome Proliferator–Activated Receptor γ Reduces Endotoxemic Pulmonary Inflammation and Injury